169 related articles for article (PubMed ID: 11734740)
41. Seroepidemiology of varicella-zoster virus in Korea.
Lee H; Cho HK; Kim KH
J Korean Med Sci; 2013 Feb; 28(2):195-9. PubMed ID: 23400233
[TBL] [Abstract][Full Text] [Related]
42. Seroprevalence of varicella-zoster virus in the German population.
Wutzler P; Färber I; Wagenpfeil S; Bisanz H; Tischer A
Vaccine; 2001 Oct; 20(1-2):121-4. PubMed ID: 11567755
[TBL] [Abstract][Full Text] [Related]
43. Varicella zoster and fever rash surveillance in Lao People's Democratic Republic.
Nouanthong P; Hübschen JM; Billamay S; Mongkhoune S; Vilivong K; Khounvisith V; Sinner R; Grandadam M; Phonekeo D; Black AP; Muller CP
BMC Infect Dis; 2019 May; 19(1):392. PubMed ID: 31068140
[TBL] [Abstract][Full Text] [Related]
44. Varicella zoster virus-associated morbidity and mortality in Africa - a systematic review.
Hussey H; Abdullahi L; Collins J; Muloiwa R; Hussey G; Kagina B
BMC Infect Dis; 2017 Nov; 17(1):717. PubMed ID: 29137604
[TBL] [Abstract][Full Text] [Related]
45. High varicella zoster virus susceptibility in Caribbean island populations: Implications for vaccination.
Vos RA; Mollema L; van Boven M; van Lier A; Smits G; Janga-Jansen AVA; Baboe-Kalpoe S; Hulshof K; Stienstra Y; van der Klis FRM; de Melker HE
Int J Infect Dis; 2020 May; 94():16-24. PubMed ID: 32112964
[TBL] [Abstract][Full Text] [Related]
46. Varicella-zoster virus susceptibility and primary healthcare consultations in Norway.
Rimseliene G; Vainio K; Gibory M; Salamanca BV; Flem E
BMC Infect Dis; 2016 Jun; 16():254. PubMed ID: 27266273
[TBL] [Abstract][Full Text] [Related]
47. The seroepidemiology of primary varicella-zoster virus infection in Flanders (Belgium).
Thiry N; Beutels P; Shkedy Z; Vranckx R; Vandermeulen C; Wielen MV; Damme PV
Eur J Pediatr; 2002 Nov; 161(11):588-93. PubMed ID: 12424583
[TBL] [Abstract][Full Text] [Related]
48. Immunofluorescence test for sensitive detection of varicella-zoster virus-specific IgG: an alternative to fluorescent antibody to membrane antigen test.
Sauerbrei A; Färber I; Brandstädt A; Schacke M; Wutzler P
J Virol Methods; 2004 Jul; 119(1):25-30. PubMed ID: 15109817
[TBL] [Abstract][Full Text] [Related]
49. Effect of climatic factors and population density on varicella zoster virus epidemiology within a tropical country.
Lolekha S; Tanthiphabha W; Sornchai P; Kosuwan P; Sutra S; Warachit B; Chup-Upprakarn S; Hutagalung Y; Weil J; Bock HL
Am J Trop Med Hyg; 2001; 64(3-4):131-6. PubMed ID: 11442207
[TBL] [Abstract][Full Text] [Related]
50. Seroepidemiology of varicella-zoster in Pakistan.
Akram DS; Qureshi H; Mahmud A; Khan AA; Kundi Z; Shafi S; N-ur-Rehman ; Olowokure B; Weil J; Bock H; Yazdani I
Southeast Asian J Trop Med Public Health; 2000 Dec; 31(4):646-9. PubMed ID: 11414405
[TBL] [Abstract][Full Text] [Related]
51. Varicella-zoster virus prevalence in Japan: no significant change in a decade.
Taylor-Wiedeman J; Yamashita K; Miyamura K; Yamazaki S
Jpn J Med Sci Biol; 1989 Feb; 42(1):1-11. PubMed ID: 2550689
[TBL] [Abstract][Full Text] [Related]
52. How reliable is the history of chickenpox? Varicella serology among children up to 14 years of age.
Kavaliotis J; Petridou S; Karabaxoglou D
Int J Infect Dis; 2003 Dec; 7(4):274-7. PubMed ID: 14656418
[TBL] [Abstract][Full Text] [Related]
53. Performance characteristics of a quantitative, standardised varicella zoster IgG time resolved fluorescence immunoassay (VZV TRFIA) for measuring antibody following natural infection.
Chris Maple PA; Gray J; Brown K; Brown D
J Virol Methods; 2009 Apr; 157(1):90-2. PubMed ID: 19135089
[TBL] [Abstract][Full Text] [Related]
54. Varicella zoster virus in health care workers in northern Israel: seroprevalence and predictive value of history of varicella infection.
Chazan B; Colodner R; Teitler N; Chen Y; Raz R
Am J Infect Control; 2008 Aug; 36(6):436-8. PubMed ID: 18675150
[TBL] [Abstract][Full Text] [Related]
55. Reduced varicella-zoster-virus (VZV)-specific lymphocytes and IgG antibody avidity in solid organ transplant recipients.
Prelog M; Schönlaub J; Jeller V; Almanzar G; Höfner K; Gruber S; Eiwegger T; Würzner R
Vaccine; 2013 May; 31(20):2420-6. PubMed ID: 23583889
[TBL] [Abstract][Full Text] [Related]
56. Varicella zoster antibodies after herpes zoster, varicella and multiple sclerosis.
Ross RT; Nicolle LE; Dawood MR; Cheang M; Feschuk C
Can J Neurol Sci; 1997 May; 24(2):137-9. PubMed ID: 9164691
[TBL] [Abstract][Full Text] [Related]
57. Low Varicella Zoster Virus Seroprevalence Among Young Children in the Democratic Republic of the Congo.
Doshi RH; Alfonso VH; Mukadi P; Hoff NA; Gerber S; Bwaka A; Higgins SG; Sinai C; Cowell B; Ngoie Mwamba G; Okitolonda E; Muyembe-Tamfum JJ; Rimoin AW
Pediatr Infect Dis J; 2018 Feb; 37(2):138-143. PubMed ID: 28834954
[TBL] [Abstract][Full Text] [Related]
58. Prior varicella zoster virus exposure in IBD patients treated by anti-TNFs and other immunomodulators: implications for serological testing and vaccination guidelines.
Kopylov U; Levin A; Mendelson E; Dovrat S; Book M; Eliakim R; Ben-Horin S
Aliment Pharmacol Ther; 2012 Jul; 36(2):145-50. PubMed ID: 22612376
[TBL] [Abstract][Full Text] [Related]
59. Varicella zoster seroprevalence in children less than 5 years old.
Ozkan S; Maral I; Ilhan F; Aycan S; Cirak MY; Beyazova U; Aygun R
J Trop Pediatr; 2005 Jun; 51(3):141-4. PubMed ID: 15831668
[TBL] [Abstract][Full Text] [Related]
60. Varicella seroprevalence in Turkish population in Cyprus.
Kurugol Z; Koturoglu G; Aksit S; Ozacar T
Acta Paediatr; 2007 Jun; 96(6):861-3. PubMed ID: 17465984
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
